Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Interest Expenses (2020 - 2026)

Journey Medical filings provide 6 years of Interest Expenses readings, the most recent being $933000.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 12.27% to $933000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.7 million, a 36.96% increase, with the full-year FY2025 number at $3.7 million, up 36.96% from a year prior.
  • Interest Expenses hit $933000.0 in Q4 2025 for Journey Medical, roughly flat from $937000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $4.1 million in Q4 2021 to a low of $24000.0 in Q4 2023.
  • Median Interest Expenses over the past 5 years was $703000.0 (2023), compared with a mean of $857450.0.
  • Biggest five-year swings in Interest Expenses: crashed 96.11% in 2023 and later soared 3362.5% in 2024.
  • Journey Medical's Interest Expenses stood at $4.1 million in 2021, then plummeted by 84.94% to $617000.0 in 2022, then crashed by 96.11% to $24000.0 in 2023, then soared by 3362.5% to $831000.0 in 2024, then rose by 12.27% to $933000.0 in 2025.
  • The last three reported values for Interest Expenses were $933000.0 (Q4 2025), $937000.0 (Q3 2025), and $937000.0 (Q2 2025) per Business Quant data.